A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

April 6, 2019

Study Completion Date

March 26, 2020

Conditions
Uremic Pruritus
Interventions
DRUG

CR845 0.5 mcg/kg

IV medication delivered three times/week

DRUG

Placebo

IV medication delivered three times/week

Trial Locations (57)

10461

Cara Therapeutics Study Site, The Bronx

11021

Cara Therapeutics Study Site, Great Neck

11365

Cara Therapeutics Study Site, Fresh Meadows

23320

Cara Therapeutics Study Site, Chesapeake

23666

Cara Therapeutics Study Site, Hampton

27704

Cara Therapeutics Study Site, Durham

33016

Cara Therapeutics Study Site, Hialeah

33071

Cara Therapeutics Study Site 1, Coral Springs

33125

Cara Therapeutics Study Site, Miami

33169

Cara Therapeutics Study Site, Miami Gardens

33614

Cara Therapeutics Study Site, Tampa

35209

Cara Therapeutics Study Site, Homewood

35805

Cara Therapeutics Study Site, Huntsville

37408

Cara Therapeutics Study Site, Chattanooga

38801

Cara Therapeutics Study Site, Tupelo

39601

Cara Therapeutics Study Site, Brookhaven

39648

Cara Therapeutics Study Site, McComb

44718

Cara Therapeutics Study Site, Canton

48066

Cara Therapeutics Study Site, Roseville

49007

Cara Therapeutics Study Site, Kalamazoo

53226

Cara Therapeutics Study Site, Wauwatosa

55404

Cara Therapeutics Study Site, Minneapolis

64111

Cara Therapeutics Study Site, Kansas City

75057

Cara Therapeutics Study Site, Lewisville

75137

Cara Therapeutics Study Site, Duncanville

75150

Cara Therapeutics Study Site, Mesquite

75165

Cara Therapeutics Study Site, Waxahachie

75231

Cara Therapeutics Study Site, Dallas

75402

Cara Therapeutics Study Site, Greenville

77054

Cara Therapeutics Study Site, Houston

78207

Cara Therapeutics Study Site, San Antonio

78503

Cara Therapeutics Study Site, McAllen

80218

Cara Therapeutics Study Site, Denver

87109

Cara Therapeutics Study Site, Albuquerque

87301

Cara Therapeutics Study Site, Gallup

89102

Cara Therapeutics Study Site, Las Vegas

89106

Cara Therapeutics Study Site, Las Vegas

90211

Cara Therapeutics Study Site 2, Beverly Hills

Cara Therapeutics Study Site, Beverly Hills

90807

Cara Therapeutics Study Site, Long Beach

91356

Cara Therapeutics Study Site, Tarzana

91762

Cara Therapeutics Study Site, Ontario

91773

Cara Therapeutics Study Site, San Dimas

91910

Cara Therapeutics Study Site, Chula Vista

91942

Cara Therapeutics, La Mesa

92025

Cara Therapeutics Study Site, Escondido

92111

Cara Therapeutics Study Site, San Diego

92505

Cara Therapeutics Study Site, Riverside

92708

Cara Therapeutics Study Site, Fountain Valley

92881

Cara Therapeutics Study Site, Corona

95661

Cara Therapeutics Study Site, Roseville

97471

Cara Therapeutics Study Site, Roseburg

93309-5030

Cara Therapeutics Study Site, Bakersfield

06606

Cara Therapeutics Study Site, Bridgeport

06112

Cara Therapeutics Study Site, Hartford

06762

Cara Therapeutics Study Site, Middlebury

07724

Cara Therapeutics Study Site, Eatontown

Sponsors
All Listed Sponsors
lead

Cara Therapeutics, Inc.

INDUSTRY